(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

122022002534

ConcedidaUtility ModelPCT · US2011053774

Application data

Number

122022002534

Type

Utility Model

Filing

09/28/2011

Publication

-

PCT

US2011053774

Progress at the INPI

  1. Filing09/28/11
  2. Publication
  3. Examination
  4. Allowance04/11/23
  5. Grant06/06/23
  6. In force09/28/26

The patent was granted on 06/06/2023 and is in force until 09/28/2026. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:09/28/2026

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/06/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AMYLIN PHARMACEUTICALS, LLC

US

A. L. (pessoa física)

US

See this company's full portfolio

Inventors

M. E. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

61/387,402 · 09/28/2010

US

61/422,091 · 12/10/2010

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Concessão da patente

#16.1

Prazo de Validade: 20 (vinte) anos contados a partir de 28/09/2011, observadas as condições legais. Patente concedida conforme ADI 5.529/DF, que determina a alteração do prazo de concessão.

06/06/2023

RPI 2735

Deferimento

#9.1

04/11/2023

RPI 2727

7.2

Anulada a publicação código 7.1 na RPI nº 2712 de 27/12/2022 por ter sido indevida.

01/10/2023

RPI 2714

Conhecimento de parecer técnico

#7.1

12/27/2022

RPI 2712

Conhecimento de parecer técnico

#7.1

06/07/2022

RPI 2683

Notificação de pedido dividido

#2.4

03/03/2022

RPI 2669

Requerimento de pedido de patente

#2.10

Número de Protocolo '870220011773' em 10/02/2022 12:24 (WB)

02/22/2022

RPI 2668

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.